SUGAPILL-M 1000
MRP: 2,400
Packaging: 10x15
Pack Type: tablet
Composition:
Vildagliptin 50mg + Metformin 1000mg Film Coated
Indication:
Type-2 Diabetes
Description:
This tablet combines Vildagliptin 50 mg, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, with Metformin Hydrochloride 1000 mg, a biguanide, to provide effective glycemic control in type 2 diabetes mellitus.
Vildagliptin enhances the body’s natural ability to control blood sugar by increasing incretin hormones, which stimulate insulin release and decrease glucagon secretion.
Metformin lowers blood glucose by reducing hepatic glucose production and improving insulin sensitivity in peripheral tissues.
The film-coated tablet offers improved tolerability and ease of administration. This combination targets multiple pathways in diabetes management to control both fasting and postprandial blood glucose levels.
Tags:
- Dual action for effective glycemic control
- Controls both fasting and post-meal glucose levels
- Metformin improves insulin sensitivity and reduces glucose production
- Vildagliptin promotes insulin release with low hypoglycemia risk
- Film-coated for better patient compliance and GI tolerance
Usage Information
Dosage
Take one tablet once or twice daily with meals Swallow whole with water; do not crush or chew Follow physician’s dosage and monitoring instructions Regular blood glucose monitoring is advised
Side Effects
Gastrointestinal upset: nausea, diarrhea, abdominal discomfort Headache, dizziness Risk of hypoglycemia, especially with other antidiabetics Rare: lactic acidosis (Metformin), pancreatitis (Vildagliptin)
Contraindications
Type 1 diabetes or diabetic ketoacidosis Severe renal or hepatic impairment Known hypersensitivity to Vildagliptin or Metformin Conditions predisposing to lactic acidosis Pregnancy and breastfeeding unless advised by a doctor
Availability
Vildagliptin Metformin combo, Vildagliptin 50mg Metformin 1000mg, Type 2 diabetes treatment, Oral antidiabetic tablet, Diabetes combination therapy